Cargando…
A model framework for projecting the prevalence and impact of Long-COVID in the UK
The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The prevalence of sy...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639065/ https://www.ncbi.nlm.nih.gov/pubmed/34855874 http://dx.doi.org/10.1371/journal.pone.0260843 |
_version_ | 1784609075172999168 |
---|---|
author | Martin, Chris Luteijn, Michiel Letton, William Robertson, Josephine McDonald, Stuart |
author_facet | Martin, Chris Luteijn, Michiel Letton, William Robertson, Josephine McDonald, Stuart |
author_sort | Martin, Chris |
collection | PubMed |
description | The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed prevalence. Both parts were combined to calculate QALY loss due to COVID-19 symptoms. Assuming a 60% final attack rate for SARS-CoV-2 infection in the population, we modelled 299,730 QALYs lost within 1 year of infection (90% due to symptomatic COVID-19 and 10% permanent injury) and 557,764 QALYs lost within 10 years of infection (49% due to symptomatic COVID-19 and 51% due to permanent injury). The UK Government willingness-to-pay to avoid these QALY losses would be £17.9 billion and £32.2 billion, respectively. Additionally, 90,143 people were subject to permanent injury from COVID-19 (0.14% of the population). Given the ongoing development in information in this area, we present a model framework for calculating the health economic impacts of symptoms following SARS-CoV-2 infection. This model framework can aid in quantifying the adverse health impact of COVID-19, long-COVID and permanent injury following COVID-19 in society and assist the proactive management of risk posed to health. Further research is needed using standardised measures of patient reported outcomes relevant to long-COVID and applied at a population level. |
format | Online Article Text |
id | pubmed-8639065 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-86390652021-12-03 A model framework for projecting the prevalence and impact of Long-COVID in the UK Martin, Chris Luteijn, Michiel Letton, William Robertson, Josephine McDonald, Stuart PLoS One Research Article The objective of this paper is to model lost Quality Adjusted Life Years (QALYs) from symptoms arising from COVID-19 disease in the UK population, including symptoms of ‘long-COVID’. The scope includes QALYs lost to symptoms, but not deaths, due to acute COVID-19 and long-COVID. The prevalence of symptomatic COVID-19, encompassing acute symptoms and long-COVID symptoms, was modelled using a decay function. Permanent injury as a result of COVID-19 infection, was modelled as a fixed prevalence. Both parts were combined to calculate QALY loss due to COVID-19 symptoms. Assuming a 60% final attack rate for SARS-CoV-2 infection in the population, we modelled 299,730 QALYs lost within 1 year of infection (90% due to symptomatic COVID-19 and 10% permanent injury) and 557,764 QALYs lost within 10 years of infection (49% due to symptomatic COVID-19 and 51% due to permanent injury). The UK Government willingness-to-pay to avoid these QALY losses would be £17.9 billion and £32.2 billion, respectively. Additionally, 90,143 people were subject to permanent injury from COVID-19 (0.14% of the population). Given the ongoing development in information in this area, we present a model framework for calculating the health economic impacts of symptoms following SARS-CoV-2 infection. This model framework can aid in quantifying the adverse health impact of COVID-19, long-COVID and permanent injury following COVID-19 in society and assist the proactive management of risk posed to health. Further research is needed using standardised measures of patient reported outcomes relevant to long-COVID and applied at a population level. Public Library of Science 2021-12-02 /pmc/articles/PMC8639065/ /pubmed/34855874 http://dx.doi.org/10.1371/journal.pone.0260843 Text en © 2021 Martin et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Martin, Chris Luteijn, Michiel Letton, William Robertson, Josephine McDonald, Stuart A model framework for projecting the prevalence and impact of Long-COVID in the UK |
title | A model framework for projecting the prevalence and impact of Long-COVID in the UK |
title_full | A model framework for projecting the prevalence and impact of Long-COVID in the UK |
title_fullStr | A model framework for projecting the prevalence and impact of Long-COVID in the UK |
title_full_unstemmed | A model framework for projecting the prevalence and impact of Long-COVID in the UK |
title_short | A model framework for projecting the prevalence and impact of Long-COVID in the UK |
title_sort | model framework for projecting the prevalence and impact of long-covid in the uk |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639065/ https://www.ncbi.nlm.nih.gov/pubmed/34855874 http://dx.doi.org/10.1371/journal.pone.0260843 |
work_keys_str_mv | AT martinchris amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT luteijnmichiel amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT lettonwilliam amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT robertsonjosephine amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT mcdonaldstuart amodelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT martinchris modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT luteijnmichiel modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT lettonwilliam modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT robertsonjosephine modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk AT mcdonaldstuart modelframeworkforprojectingtheprevalenceandimpactoflongcovidintheuk |